The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 28, 2004

Filed:

Dec. 28, 2001
Applicant:
Inventors:

Yasuaki Itoh, Ibaraki, JP;

Kazunori Nishi, London, GB;

Kazuhiro Ogi, Ibaraki, JP;

Shoichi Ohkubo, Ibaraki, JP;

Shinichi Mogi, Ibaraki, JP;

Yuko Noguchi, Ibaraki, JP;

Koji Yoshimura, Ibaraki, JP;

Hideyuki Tanaka, Ibaraki, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 3/353 ; C12P 2/106 ; C12N 1/587 ; C12N 1/20 ; C12N 1/574 ; C07H 2/104 ; C07K 1/400 ; C07K 1/708 ;
U.S. Cl.
CPC ...
G01N 3/353 ; C12P 2/106 ; C12N 1/587 ; C12N 1/20 ; C12N 1/574 ; C07H 2/104 ; C07K 1/400 ; C07K 1/708 ;
Abstract

The present invention relates to novel secretory polypeptides and precursor proteins thereof, which show a high homology to MIA (melanoma inhibitor activity)/CD-RAP (bovine cartilage-derived retinoic acid-sensitive protein); are specifically expressed in the cartilage tissue; and have an effect on the cartilage differentiation. The polypeptides and the DNAs encoding the same can be used for the diagnosis, treatment, or prevention of bone and joint diseases or pathological angiogenesis. As well, the polypeptides are useful as a reagent for screening a compound that promotes or inhibits the activity of the polypeptides. The antibody to the polypeptides can be used for the detection, quantification, or neutralization of the polypeptide in a test sample fluid. Further by using the promoter of the present invention, a therapeutic protein can be expressed predominantly in the cartilage tissue for a gene therapy.


Find Patent Forward Citations

Loading…